T- and B-Cells in the Inner Invasive Margin of Hepatocellular Carcinoma after Resection Associate with Favorable Prognosis
Authors:
- Andriy TrailinATAndriy Trailin
- Lenka ČervenkováLČLenka Červenková
- Filip AmbrozkiewiczFAFilip Ambrozkiewicz
- Esraa AliEAEsraa Ali
- Phanindra KasiPKPhanindra Kasi
- Richard PálekRPRichard Pálek
- Petr HošekPHPetr Hošek
- Vladislav TřeškaVTVladislav Třeška
- Ondrej DaumODOndrej Daum
- Zbyněk TonarZTZbyněk Tonar
- Václav LiškaVLVáclav Liška
- Kari HemminkiKari Hemminki
Open Access
Abstract
In this retrospective study on 67 patients with hepatocellular carcinoma (HCC), after tumor resection, we evaluated the significance of CD3+ and CD8+ T-lymphocytes and CD20+ B-lymphocytes in tumor and non-tumor liver for time to recurrence (TTR), disease-free survival (DFS) and overall survival. After immunohistochemical staining, the density of nucleated lymphocyte profiles (QA) was estimated stereologically in the tumor center (TC), inner margin (inn M), outer margin (out M), peritumor and non-tumor liver. In TC, intermediate and high QA of CD8+ cells predicted longer TTR, whereas CD3+ and CD20+ were predictive only at high QA. DFS was predicted by high QA of CD3+, CD8+ and CD20+ cells in TC. The inn M harbored smaller QA of CD3+, CD8+ and CD20+ lymphocytes than out M. In contrast to out M, high T-cells’ QA and intermediate and high B-cell QA in inn M predicted longer TTR and DFS. High inn M/out M QA ratios of CD3+ and CD20+ cells were associated with longer TTR and DFS, whereas high inn M/out M QA ratio of CD8+ was predictive only for DFS. Patients with intermediate-high QA of combined CD8+ and CD20+ cells in inn M showed longer TTR and DFS, compared to CD8+-high or CD20+-high alone. Our findings highlight overall heterogeneity of the tumor invasive margin, the importance of inn M, and the predictive role of B-cells.Keywords
Funding Information
- European Union's Horizon 2020 research and innovation programme (856620)
- Ministerstvo Zdravotnictví Ceské Republiky (AZV NU21-03-00506)
- Charles University Research Fund (Progres Q39)
This publication has 39 references indexed in Scilit:
- Liver‐infiltrating CD8+ lymphocytes as prognostic factor for tumour recurrence in hepatitis C virus‐related hepatocellular carcinomaLiver International, 2015
- T cell exclusion, immune privilege, and the tumor microenvironmentScience, 2015
- Tertiary lymphoid structures are associated with higher tumor grade in primary operable breast cancer patientsBMC Cancer, 2015
- Tumor‐infiltrating, interleukin‐33–producing effector‐memory CD8+ T cells in resected hepatocellular carcinoma prolong patient survivalHepatology, 2015
- The morphological growth patterns of colorectal liver metastases are prognostic for overall survivalLaboratory Investigation, 2014
- Margin-Infiltrating CD20+ B Cells Display an Atypical Memory Phenotype and Correlate with Favorable Prognosis in Hepatocellular CarcinomaClinical Cancer Research, 2013
- Resection of hepatocellular cancer ≤2 cm: Results from two Western centersHepatology, 2012
- Effector and regulatory B cells: modulators of CD4+ T cell immunityNature Reviews Immunology, 2010
- Edmondson‐Steiner Grading Increases the Predictive Efficiency of TNM Staging for Long‐term Survival of Patients with Hepatocellular Carcinoma After Curative ResectionWorld Journal of Surgery, 2008
- Histological grading and staging of chronic hepatitisJournal of Hepatology, 1995